Ethical issues related to BRCA gene testing in Orthodox Jewish women

Nursing Ethics

Volumn 15, Issue 4, 2008, Pages 512-522

  Mor, Pnina ^a,b   Oberle, Kathleen ^b  

^a University of Calgary ^*  (Israel)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

BRCA gene; Ethics and genetics; Genetics testing; Healthy carriers; Jewish ethics; Orthodox Jewish women

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO HEALTH; BREAST TUMOR; CASE REPORT; CONFIDENTIALITY; DECISION MAKING; ETHICS; ETHNOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HETEROZYGOTE DETECTION; HUMAN; INFORMED CONSENT; ISRAEL; JEW; MEDICAL ETHICS; MUTATION; NURSE ATTITUDE; OVARY TUMOR; PSYCHOLOGICAL ASPECT; RELIGION; TUMOR SUPPRESSOR GENE; WOMEN'S HEALTH;

ADULT; ATTITUDE TO HEALTH; BREAST NEOPLASMS; CODES OF ETHICS; CONFIDENTIALITY; DECISION MAKING; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMANS; INFORMED CONSENT; ISRAEL; JEWS; JUDAISM; MUTATION; NURSE'S ROLE; OVARIAN NEOPLASMS; RELIGION AND MEDICINE; WOMEN'S HEALTH;

EID: 46149103202     PISSN: 09697330     EISSN: 14770989     Source Type: Journal    
DOI: 10.1177/09697330080150041201     Document Type: Article

References (36)

1. Kirk MTE, Gaff C. Primary care nursing and genetics: it isn't part of your role ... is it? Primary Health Care 2003; 16(7): 34-36.
2. Frazier LMJ, Dea DH, Boerwinkle E. Genetics discoveries and nursing implications for complex disease prevention and management. J Prof Nurs 2004; 20: 222-29.
3. Haydon J. Genetics: uphold the rights of all clients to informed decision-making and voluntary action. Nurs Stand 2005; 20(3): 48-51.
4. Lewis ACK, Jenkins J. Essential nursing competencies and curricula guidelines for genetics and genomics. MCN Am J Matern Child Nurs 2006; 31: 146-53.
5. American Nurses Association. Code for nurses with interpretive statements. Washington, DC: American Nurses Publishing, 2001.
6. Anderson G. After the sequencing of the human genome: new opportunities for nurses abound [Report]. Nurs Ethics 2001; 8: 473-74.
7. King M-C, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003; 302: 643-46.
8. Levy-Lahad E, Plon SE. Cancer enhanced: a risky business - assessing breast cancer risk. Science 2003; 302: 574-75.
9. Neuhausen S, Gilewski T, Norton L et al. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet 1996; 13: 126-68.
10. Offit K, Gilewski T, McGuire P et al. Germline BRCA1 185delAG mutations in Jewish women with breast cancer. Lancet 1996; 347: 1643-45.
11. Tonin P, Serova'O, Lenoir G et al. BRCA1 mutations in Ashkenazi Jewish women. Am J Hum Genet 1995; 57: 189.
12. Tonin P, Weber B, Offit K et al. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med 1996; 2: 1179-83.
13. Callahan D. Principlism and communitarianism. J Med Ethics 2003; 29: 287-91.
14. Steinberg A. Encyclopedia of Jewish medical ethics, second edition. Jerusalem: Feldheim, 2003.
15. Jakobovits I. The timely and the timeless: Judaism and society in a storm-tossed decade. New York: Bloch, 1989: 128.
16. Stirrat GM, Gill R. Autonomy in medical ethics after O'Neill. J Med Ethics 2005; 31: 127-30.
17. Ashcroft RE, Chadwick W, Clark SRL, Edwards RHT, Frith L, Hutton JL. Implication of socio-cultural contexts for the ethics of clinical trials. Health Technol Assess 1997; 1(9): 1-67.
18. Epstein M. Why effective consent presupposes autonomous authorisation: a counterorthodox argument. J Med Ethics 2006; 32: 342-45.
19. Claes E, Evers-Kiebooms G, Decruyenaere M et al. Surveillance behaviour and prophylactic surgery after predictive testing for hereditary breast/ovarian cancer. Behav Med 2005; 31: 93-105.
20. Morrow MGW. Recent developments: breast cancer review. BMJ 2002; 324: 410-14.
21. Rebbeck TR, Levin AM, Eisen A et al. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 1999; 91: 1475-79.
22. Robson ME. Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer. Cancer Control 2002; 9: 457-65.
23. Herrinton LJ, Barlow WE, Yu O et al. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol 2005; 23: 4275-86.
24. Struewing JP, Hartge P, Wacholder S et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 336: 1401-408.
25. Eisenberg D. The ethics of genetic screening. 2007. Retrieved 29 January, 2008, from: http://www.aish.com/societyWork/sciencenature
26. Fisch H ed. The Jerusalem Bible. Jerusalem: Koren, 1984.
27. Babylonian Talmud, Yebamoth 65b.
28. Giarelli E. Safeguarding being: a bioethical principle for genetic nursing care, Nurs Ethics 2003; 10: 255-68.
29. Hartmann LC, Degnim AS, Schaid DJ. Prophylactic mastectomy for BRCA1/2 carriers: progress and more questions. J Clin Oncol 2004; 22: 981-83.
30. Hallowell N. Doing the right thing: genetic risk and responsibility. Soc Health Illness 1999; 21: 597-621.
31. Auerbach B, Shadmi AM eds. Nachmadides, Toras Ha'Adam, Inyan Ha'Sakana. (The human doctrine: the issues concerning the matter of danger.) Jerusalem: Mossad Harav Kook, 1993 (in Hebrew).
32. Beis Yosef Yoreh De'ah 241: 3.
33. Rosner F. Judaism, genetic screening, and genetic therapy. Mt Sinai J Med 1998; 65: 406-13.
34. Tosafot commentary to Babylonian Talmud Gittin 20b.
35. Shulhan Arukh, Yoreh De'ah.
36. Pliskin Z. Guard your tongue. A practical guide to the laws of loshon hora [gossip/tale bearing] based on Chofetz Chayim. Jerusalem: Bnay Yaakov, 1975: 237 (English version).